Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791043578> ?p ?o ?g. }
- W2791043578 endingPage "850" @default.
- W2791043578 startingPage "841" @default.
- W2791043578 abstract "IntroductionHyporesponsiveness to recombinant human erythropoietin (rhEPO) is a major problem affecting some patients with chronic kidney disease (CKD), predominantly those on hemodialysis (HD). Daprodustat (GSK1278863) is a hypoxia-inducible factor prolyl hydroxylase inhibitor that is being investigated as a treatment for anemia of CKD.MethodsThis phase 2a, exploratory, multicenter, single-arm study assessed the ability of daprodustat to increase or maintain hemoglobin concentrations within the target range (10.0–11.5 g/dl) over 16 weeks in subjects with anemia who were on HD and who had a high erythropoietin resistance index (ERI). All included subjects met the criteria for chronic rhEPO hyporesponsiveness (i.e., an ERI based on a series of contiguous strata of patients’ hemoglobin-by−epoetin alfa for a minimum of 12 weeks). Eligible adults were on a stable HD regimen 3 to 4 times per week. Markers of iron utilization and safety were also assessed. All subjects initially received oral daprodustat 12 mg once daily.ResultsOf the 60 participants screened, 15 were enrolled, and 7 (47%) completed 16 weeks of treatment. At week 16, 2 of 7 subjects (29%) had >1 g/dl increases in hemoglobin from baseline. Daprodustat had minimal effects on markers of iron metabolism and utilization. Fourteen subjects (93%) experienced ≥1 adverse event (AE). The most common AEs included nausea, pneumonia, pleural effusion, and urinary tract infection. The majority of on-therapy AEs were mild or moderate in intensity.ConclusionDaprodustat increased hemoglobin concentrations within the target range in 29% of chronic rhEPO-hyporesponsive subjects. No new safety concerns were identified in this short exploratory study." @default.
- W2791043578 created "2018-03-29" @default.
- W2791043578 creator A5014367124 @default.
- W2791043578 creator A5018809489 @default.
- W2791043578 creator A5046534481 @default.
- W2791043578 creator A5089317996 @default.
- W2791043578 creator A5091644172 @default.
- W2791043578 date "2018-07-01" @default.
- W2791043578 modified "2023-10-12" @default.
- W2791043578 title "An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects" @default.
- W2791043578 cites W1483052423 @default.
- W2791043578 cites W1586488555 @default.
- W2791043578 cites W1802836383 @default.
- W2791043578 cites W1965933415 @default.
- W2791043578 cites W1989745279 @default.
- W2791043578 cites W2016632653 @default.
- W2791043578 cites W2033803279 @default.
- W2791043578 cites W2065723138 @default.
- W2791043578 cites W2074456535 @default.
- W2791043578 cites W2080061193 @default.
- W2791043578 cites W2097586983 @default.
- W2791043578 cites W2117616342 @default.
- W2791043578 cites W2129312245 @default.
- W2791043578 cites W2135454486 @default.
- W2791043578 cites W2170328739 @default.
- W2791043578 cites W2178101235 @default.
- W2791043578 cites W2206481924 @default.
- W2791043578 cites W2268447664 @default.
- W2791043578 cites W2339445416 @default.
- W2791043578 cites W2520158967 @default.
- W2791043578 cites W2562262017 @default.
- W2791043578 cites W2580449060 @default.
- W2791043578 cites W2608113875 @default.
- W2791043578 cites W2790701104 @default.
- W2791043578 cites W2799655697 @default.
- W2791043578 doi "https://doi.org/10.1016/j.ekir.2018.02.009" @default.
- W2791043578 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6035126" @default.
- W2791043578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29989040" @default.
- W2791043578 hasPublicationYear "2018" @default.
- W2791043578 type Work @default.
- W2791043578 sameAs 2791043578 @default.
- W2791043578 citedByCount "24" @default.
- W2791043578 countsByYear W27910435782019 @default.
- W2791043578 countsByYear W27910435782020 @default.
- W2791043578 countsByYear W27910435782021 @default.
- W2791043578 countsByYear W27910435782022 @default.
- W2791043578 countsByYear W27910435782023 @default.
- W2791043578 crossrefType "journal-article" @default.
- W2791043578 hasAuthorship W2791043578A5014367124 @default.
- W2791043578 hasAuthorship W2791043578A5018809489 @default.
- W2791043578 hasAuthorship W2791043578A5046534481 @default.
- W2791043578 hasAuthorship W2791043578A5089317996 @default.
- W2791043578 hasAuthorship W2791043578A5091644172 @default.
- W2791043578 hasBestOaLocation W27910435781 @default.
- W2791043578 hasConcept C126322002 @default.
- W2791043578 hasConcept C197934379 @default.
- W2791043578 hasConcept C2775989426 @default.
- W2791043578 hasConcept C2777417653 @default.
- W2791043578 hasConcept C2778063415 @default.
- W2791043578 hasConcept C2778248108 @default.
- W2791043578 hasConcept C2778534260 @default.
- W2791043578 hasConcept C2778653478 @default.
- W2791043578 hasConcept C2778917026 @default.
- W2791043578 hasConcept C2780580376 @default.
- W2791043578 hasConcept C2781413609 @default.
- W2791043578 hasConcept C71924100 @default.
- W2791043578 hasConcept C90924648 @default.
- W2791043578 hasConceptScore W2791043578C126322002 @default.
- W2791043578 hasConceptScore W2791043578C197934379 @default.
- W2791043578 hasConceptScore W2791043578C2775989426 @default.
- W2791043578 hasConceptScore W2791043578C2777417653 @default.
- W2791043578 hasConceptScore W2791043578C2778063415 @default.
- W2791043578 hasConceptScore W2791043578C2778248108 @default.
- W2791043578 hasConceptScore W2791043578C2778534260 @default.
- W2791043578 hasConceptScore W2791043578C2778653478 @default.
- W2791043578 hasConceptScore W2791043578C2778917026 @default.
- W2791043578 hasConceptScore W2791043578C2780580376 @default.
- W2791043578 hasConceptScore W2791043578C2781413609 @default.
- W2791043578 hasConceptScore W2791043578C71924100 @default.
- W2791043578 hasConceptScore W2791043578C90924648 @default.
- W2791043578 hasIssue "4" @default.
- W2791043578 hasLocation W27910435781 @default.
- W2791043578 hasLocation W27910435782 @default.
- W2791043578 hasLocation W27910435783 @default.
- W2791043578 hasLocation W27910435784 @default.
- W2791043578 hasLocation W27910435785 @default.
- W2791043578 hasOpenAccess W2791043578 @default.
- W2791043578 hasPrimaryLocation W27910435781 @default.
- W2791043578 hasRelatedWork W102865230 @default.
- W2791043578 hasRelatedWork W2128726523 @default.
- W2791043578 hasRelatedWork W2364659167 @default.
- W2791043578 hasRelatedWork W2388094315 @default.
- W2791043578 hasRelatedWork W2393785919 @default.
- W2791043578 hasRelatedWork W2412425337 @default.
- W2791043578 hasRelatedWork W2804407089 @default.
- W2791043578 hasRelatedWork W2805683016 @default.
- W2791043578 hasRelatedWork W2885191723 @default.
- W2791043578 hasRelatedWork W4377820566 @default.